1. Home
  2. CRIS vs KPLT Comparison

CRIS vs KPLT Comparison

Compare CRIS & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • KPLT
  • Stock Information
  • Founded
  • CRIS 2000
  • KPLT 2012
  • Country
  • CRIS United States
  • KPLT United States
  • Employees
  • CRIS N/A
  • KPLT N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • KPLT Diversified Commercial Services
  • Sector
  • CRIS Health Care
  • KPLT Consumer Discretionary
  • Exchange
  • CRIS Nasdaq
  • KPLT Nasdaq
  • Market Cap
  • CRIS 22.9M
  • KPLT 97.4M
  • IPO Year
  • CRIS 2000
  • KPLT N/A
  • Fundamental
  • Price
  • CRIS $1.70
  • KPLT $23.07
  • Analyst Decision
  • CRIS Strong Buy
  • KPLT Hold
  • Analyst Count
  • CRIS 2
  • KPLT 1
  • Target Price
  • CRIS $16.50
  • KPLT $10.00
  • AVG Volume (30 Days)
  • CRIS 75.9K
  • KPLT 90.7K
  • Earning Date
  • CRIS 11-13-2025
  • KPLT 11-05-2025
  • Dividend Yield
  • CRIS N/A
  • KPLT N/A
  • EPS Growth
  • CRIS N/A
  • KPLT N/A
  • EPS
  • CRIS N/A
  • KPLT N/A
  • Revenue
  • CRIS $11,405,000.00
  • KPLT $267,101,999.00
  • Revenue This Year
  • CRIS $1.41
  • KPLT $22.88
  • Revenue Next Year
  • CRIS $7.46
  • KPLT $10.98
  • P/E Ratio
  • CRIS N/A
  • KPLT N/A
  • Revenue Growth
  • CRIS 12.24
  • KPLT 13.04
  • 52 Week Low
  • CRIS $1.02
  • KPLT $5.08
  • 52 Week High
  • CRIS $6.44
  • KPLT $24.34
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 47.75
  • KPLT 69.25
  • Support Level
  • CRIS $1.63
  • KPLT $17.10
  • Resistance Level
  • CRIS $1.95
  • KPLT $24.34
  • Average True Range (ATR)
  • CRIS 0.14
  • KPLT 2.34
  • MACD
  • CRIS 0.02
  • KPLT 0.26
  • Stochastic Oscillator
  • CRIS 26.47
  • KPLT 88.55

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

Share on Social Networks: